P Mark Hogarth - Publications

Affiliations: 
University of Melbourne, Parkville, Victoria, Australia 

96/284 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Haycroft ER, Davis SK, Ramanathan P, Lopez E, Purcell RA, Tan LL, Pymm P, Wines BD, Hogarth PM, Wheatley AK, Juno JA, Redmond SJ, Gherardin NA, Godfrey DI, Tham WH, et al. Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants. Medical Microbiology and Immunology. PMID 37477828 DOI: 10.1007/s00430-023-00773-w  0.318
2023 Chenoweth AM, Esparon S, Wines BD, Schuurman J, Labrijn AF, Hogarth PM. Mutation of the TGN1412 anti-CD28 Monoclonal Antibody Lower Hinge Confers Specific FcγRIIb Binding and Retention of Super-Agonist Activity. Immunology and Cell Biology. PMID 36997299 DOI: 10.1111/imcb.12646  0.32
2021 Wines BD, Trist HM, Esparon S, Impey RE, Mackay GA, Andrews RK, Soares da Costa TP, Pietersz GA, Baker RI, Hogarth PM. Fc Binding by FcγRIIa Is Essential for Cellular Activation by the Anti-FcγRIIa mAbs 8.26 and 8.2. Frontiers in Immunology. 12: 666813. PMID 34759915 DOI: 10.3389/fimmu.2021.666813  0.385
2021 Edwards JM, Heydarchi B, Khoury G, Salazar-Quiroz NA, Gonelli CA, Wines B, Hogarth PM, Kristensen AB, Parsons MS, Purcell DF. Enhancement of antibody-dependent cellular cytotoxicity and phagocytosis in anti-HIV-1 bovine chimeric broadly-neutralizing antibodies. Journal of Virology. PMID 33853957 DOI: 10.1128/JVI.00219-21  0.304
2020 Suphaphiphat K, Bernard-Stoecklin S, Gommet C, Delache B, Dereuddre-Bosquet N, Kent SJ, Wines BD, Hogarth PM, Le Grand R, Cavarelli M. Innate and Adaptive Anti-SIV Responses in Macaque Semen: Implications for Infectivity and Risk of Transmission. Frontiers in Immunology. 11: 850. PMID 32528466 DOI: 10.3389/Fimmu.2020.00850  0.328
2020 Kurtovic L, Atre T, Feng G, Wines BD, Chan JA, Boyle MJ, Drew DR, Hogarth PM, Fowkes FJI, Bergmann-Leitner ES, Beeson JG. Multi-functional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase I/IIa trial. The Journal of Infectious Diseases. PMID 32236404 DOI: 10.1093/Infdis/Jiaa144  0.307
2020 Chenoweth AM, Wines BD, Anania JC, Hogarth PM. Harnessing the immune system via FcγR function in immune therapy: A pathway to next‐gen mAbs Immunology and Cell Biology. 98: 287-304. PMID 32157732 DOI: 10.1111/Imcb.12326  0.408
2019 Lopez E, Scott NE, Wines BD, Hogarth PM, Wheatley AK, Kent SJ, Chung AW. Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions. Frontiers in Immunology. 10: 2415. PMID 31681303 DOI: 10.3389/Fimmu.2019.02415  0.395
2019 Abadir E, Gasiorowski RE, Lai K, Kupresanin F, Romano A, Silveira PA, Lo TH, Fromm PD, Kennerson ML, Iland HJ, Ho PJ, Hogarth PM, Bradstock K, Hart DNJ, Clark GJ. CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation. Molecular Oncology. PMID 31338922 DOI: 10.1002/1878-0261.12549  0.405
2019 Billings H, Wines B, Dyer W, Center R, Trist HM, Kent SJ, Hogarth PM. Boosting of markers of FcγR function in anti-HIV antibodies during structured treatment interruption. Aids Research and Human Retroviruses. PMID 31288562 DOI: 10.1089/Aid.2019.0047  0.383
2019 Anania JC, Chenoweth AM, Wines BD, Hogarth PM. The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease. Frontiers in Immunology. 10: 464. PMID 30941127 DOI: 10.3389/Fimmu.2019.00464  0.37
2018 Parsons MS, Lee WS, Kristensen AB, Amarasena T, Khoury G, Wheatley AK, Reynaldi A, Wines BD, Hogarth PM, Davenport MP, Kent SJ. Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques. The Journal of Clinical Investigation. PMID 30475230 DOI: 10.1172/Jci122466  0.339
2018 Anand SP, Prévost J, Baril S, Richard J, Medjahed H, Chapleau JP, Tolbert WD, Kirk S, Smith AB, Wines BD, Kent SJ, Hogarth PM, Parsons MS, Pazgier M, Finzi A. Two families of Env antibodies efficiently engage Fc-gamma receptors and eliminate HIV-1-infected cells. Journal of Virology. PMID 30429344 DOI: 10.1128/Jvi.01823-18  0.404
2018 Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, ... ... Hogarth PM, et al. The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1. Frontiers in Immunology. 9: 1809. PMID 30177930 DOI: 10.3389/Fimmu.2018.01809  0.317
2018 Vanderven HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, Jegaskanda S, Wheatley AK, Wentworth D, Wines BD, Hogarth PM, Rockman S, Kent SJ. Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection. The Journal of Infectious Diseases. 218: 1383-1393. PMID 29860297 DOI: 10.1093/Infdis/Jiy328  0.312
2017 Parsons MS, Lloyd SB, Lee WS, Kristensen AB, Amarasena T, Center RJ, Keele BF, Lifson JD, LaBranche CC, Montefiori D, Wines BD, Hogarth PM, Swiderek KM, Venturi V, Davenport MP, et al. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Science Translational Medicine. 9. PMID 28794282 DOI: 10.1126/Scitranslmed.Aaf1483  0.325
2017 Madhavi V, Wines BD, Amin J, Emery S, Lopez E, Kelleher A, Center RJ, Hogarth PM, Chung AW, Kent SJ, Stratov I. HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV. Journal of Virology. PMID 28701393 DOI: 10.1128/Jvi.00700-17  0.321
2017 McLean MR, Madhavi V, Wines BD, Hogarth PM, Chung AW, Kent SJ. Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial. Journal of Immunology (Baltimore, Md. : 1950). PMID 28615419 DOI: 10.4049/Jimmunol.1602161  0.39
2017 Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, et al. A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. Frontiers in Immunology. 8: 595. PMID 28596770 DOI: 10.3389/Fimmu.2017.00595  0.319
2017 Lee WS, Kristensen AB, Rasmussen TA, Tolstrup M, Østergaard L, Søgaard OS, Wines BD, Hogarth PM, Reynaldi A, Davenport MP, Emery S, Amin J, Cooper DA, Kan VL, Fox J, et al. Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption. Journal of Virology. PMID 28539449 DOI: 10.1128/Jvi.00603-17  0.318
2017 Wines BD, Billings H, Mclean MR, Kent SJ, Hogarth PM. HIV-specific ADCC - new technologies to study ADCC and importance for the HIV vaccine field. Current Hiv Research. PMID 28322167 DOI: 10.2174/1570162X15666170320112247  0.375
2016 Franks SE, Getahun A, Hogarth PM, Cambier JC. Targeting B cells in treatment of autoimmunity. Current Opinion in Immunology. 43: 39-45. PMID 27718447 DOI: 10.1016/J.Coi.2016.09.003  0.312
2016 Brandsma AM, Hogarth PM, Nimmerjahn F, Leusen JH. Clarifying the Confusion between Cytokine and Fc Receptor "Common Gamma Chain". Immunity. 45: 225-6. PMID 27533005 DOI: 10.1016/J.Immuni.2016.07.006  0.392
2016 Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS, Kent SJ. What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins. Ebiomedicine. 8: 277-290. PMID 27428437 DOI: 10.1016/J.Ebiom.2016.04.029  0.337
2016 Wines BD, Vanderven HA, Esparon SE, Kristensen AB, Kent SJ, Hogarth PM. Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG. Journal of Immunology (Baltimore, Md. : 1950). PMID 27385782 DOI: 10.4049/Jimmunol.1502551  0.485
2015 Chenoweth AM, Trist HM, Tan PS, Wines BD, Hogarth PM. The high-affinity receptor for IgG, FcγRI, of humans and non-human primates. Immunological Reviews. 268: 175-91. PMID 26497520 DOI: 10.1111/Imr.12366  0.422
2015 Hogarth PM. Fc Receptors: Introduction. Immunological Reviews. 268: 1-5. PMID 26497509 DOI: 10.1111/Imr.12372  0.379
2014 Hogarth PM, Anania JC, Wines BD. The FcγR of humans and non-human primates and their interaction with IgG: implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies. Current Topics in Microbiology and Immunology. 382: 321-52. PMID 25116107 DOI: 10.1007/978-3-319-07911-0_15  0.403
2014 Ko KK, Powell MS, Hogarth PM. ZSWIM1: a novel biomarker in T helper cell differentiation. Immunology Letters. 160: 133-8. PMID 24508175 DOI: 10.1016/J.Imlet.2014.01.016  0.303
2014 Trist HM, Tan PS, Wines BD, Ramsland PA, Orlowski E, Stubbs J, Gardiner EE, Pietersz GA, Kent SJ, Stratov I, Burton DR, Hogarth PM. Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses. Journal of Immunology (Baltimore, Md. : 1950). 192: 792-803. PMID 24342805 DOI: 10.4049/Jimmunol.1301554  0.324
2012 Hogarth PM, Pietersz GA. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nature Reviews. Drug Discovery. 11: 311-31. PMID 22460124 DOI: 10.1038/Nrd2909  0.384
2011 Ramsland PA, Farrugia W, Bradford TM, Sardjono CT, Esparon S, Trist HM, Powell MS, Tan PS, Cendron AC, Wines BD, Scott AM, Hogarth PM. Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes. Journal of Immunology (Baltimore, Md. : 1950). 187: 3208-17. PMID 21856937 DOI: 10.4049/Jimmunol.1101467  0.426
2011 Xia YC, Schuliga M, Shepherd M, Powell M, Harris T, Langenbach SY, Tan PS, Gerthoffer WT, Hogarth PM, Stewart AG, Mackay GA. Functional expression of IgG-Fc receptors in human airway smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology. 44: 665-72. PMID 20595464 DOI: 10.1165/Rcmb.2009-0371Oc  0.411
2010 Van de Velde NC, Mottram PL, Powell MS, Lim B, Holmdahl R, Hogarth PM. Transgenic mice expressing human FcgammaRIIa have enhanced sensitivity to induced autoimmune arthritis as well as elevated Th17 cells. Immunology Letters. 130: 82-8. PMID 20005897 DOI: 10.1016/J.Imlet.2009.12.005  0.347
2010 Cady CT, Powell MS, Harbeck RJ, Giclas PC, Murphy JR, Katial RK, Weber RW, Hogarth PM, Johnson S, Bonvini E, Koenig S, Cambier JC. IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB. Immunology Letters. 130: 57-65. PMID 20004689 DOI: 10.1016/J.Imlet.2009.12.001  0.445
2009 Pietersz GA, Mottram PL, van de Velde NC, Sardjono CT, Esparon S, Ramsland PA, Moloney G, Baell JB, McCarthy TD, Matthews BR, Powell MS, Hogarth PM. Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities. Immunology and Cell Biology. 87: 3-12. PMID 19030019 DOI: 10.1038/Icb.2008.82  0.398
2008 Cendron AC, Wines BD, Brownlee RT, Ramsland PA, Pietersz GA, Hogarth PM. An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG. Molecular Immunology. 45: 307-19. PMID 17673295 DOI: 10.1016/J.Molimm.2007.06.152  0.414
2006 van de Velde NC, Mottram PL, Hogarth PM. FcgammaRII and multi-system autoimmune disease. Springer Seminars in Immunopathology. 28: 329-38. PMID 17091247 DOI: 10.1007/S00281-006-0056-X  0.343
2006 Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens. 68: 103-14. PMID 16866880 DOI: 10.1111/J.1399-0039.2006.00613.X  0.437
2006 Powell MS, Barnes NC, Bradford TM, Musgrave IF, Wines BD, Cambier JC, Hogarth PM. Alteration of the Fc gamma RIIa dimer interface affects receptor signaling but not ligand binding. Journal of Immunology (Baltimore, Md. : 1950). 176: 7489-94. PMID 16751395 DOI: 10.4049/Jimmunol.176.12.7489  0.467
2006 Wines BD, Trist HM, Ramsland PA, Hogarth PM. A common site of the Fc receptor gamma subunit interacts with the unrelated immunoreceptors FcalphaRI and FcepsilonRI. The Journal of Biological Chemistry. 281: 17108-17113. PMID 16627486 DOI: 10.1074/Jbc.M601640200  0.438
2006 Wines BD, Willoughby N, Fraser JD, Hogarth PM. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA. The Journal of Biological Chemistry. 281: 1389-93. PMID 16293625 DOI: 10.1074/Jbc.M509334200  0.441
2005 Tan Sardjono C, Mottram PL, van de Velde NC, Powell MS, Power D, Slocombe RF, Wicks IP, Campbell IK, McKenzie SE, Brooks M, Stevenson AW, Hogarth PM. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-transgenic mice. Arthritis and Rheumatism. 52: 3220-9. PMID 16200626 DOI: 10.1002/Art.21344  0.394
2005 Corbett AJ, Caminschi I, McKenzie BS, Brady JL, Wright MD, Mottram PL, Hogarth PM, Hodder AN, Zhan Y, Tarlinton DM, Shortman K, Lew AM. Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional "danger" European Journal of Immunology. 35: 2815-2825. PMID 16143986 DOI: 10.1002/Eji.200526100  0.348
2004 Lau LM, Wee JL, Wright MD, Moseley GW, Hogarth PM, Ashman LK, Jackson DE. The tetraspanin superfamily member CD151 regulates outside-in integrin alphaIIbbeta3 signaling and platelet function. Blood. 104: 2368-75. PMID 15226180 DOI: 10.1182/Blood-2003-12-4430  0.306
2004 Ramsland PA, Farrugia W, Bradford TM, Hogarth PM, Scott AM. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens. Journal of Molecular Biology. 340: 809-818. PMID 15223322 DOI: 10.1016/J.Jmb.2004.05.037  0.377
2004 Wines BD, Trist HM, Monteiro RC, Van Kooten C, Hogarth PM. Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression, and function. The Journal of Biological Chemistry. 279: 26339-45. PMID 15096494 DOI: 10.1074/Jbc.M403684200  0.429
2003 Tan Sardjono C, Mottram PL, Hogarth PM. The role of FcgammaRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus. Immunology and Cell Biology. 81: 374-81. PMID 12969325 DOI: 10.1046/J.1440-1711.2003.01182.X  0.395
2003 Thai le M, Ashman LK, Harbour SN, Hogarth PM, Jackson DE. Physical proximity and functional interplay of PECAM-1 with the Fc receptor Fc gamma RIIa on the platelet plasma membrane. Blood. 102: 3637-45. PMID 12893767 DOI: 10.1182/Blood-2003-02-0496  0.324
2003 Tan PS, Gavin AL, Barnes N, Sears DW, Vremec D, Shortman K, Amigorena S, Mottram PL, Hogarth PM. Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 2549-56. PMID 12594281 DOI: 10.4049/Jimmunol.170.5.2549  0.435
2002 Hogarth PM. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Current Opinion in Immunology. 14: 798-802. PMID 12413532 DOI: 10.1016/S0952-7915(02)00409-0  0.433
2002 Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM. FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity. 16: 379-89. PMID 11911823 DOI: 10.1016/S1074-7613(02)00287-X  0.408
2002 Mackay GA, Hulett MD, Cook JP, Trist HM, Henry AJ, McDonnell JM, Beavil AJ, Beavil RL, Sutton BJ, Hogarth PM, Gould HJ. Mutagenesis within human FcepsilonRIalpha differentially affects human and murine IgE binding. Journal of Immunology (Baltimore, Md. : 1950). 168: 1787-95. PMID 11823511 DOI: 10.4049/Jimmunol.168.4.1787  0.649
2002 Pietersz GA, Powell MS, Ramsland PA, Hogarth PM. Chapter 22. Fc receptor structure and the design of anti-inflammatories: New therapeutics for autoimmune disease Annual Reports in Medicinal Chemistry. 37: 217-224. DOI: 10.1016/S0065-7743(02)37023-4  0.329
2001 Hulett MD, Pagler E, Hornby JR, Hogarth PM, Eyre HJ, Baker E, Crawford J, Sutherland GR, Ohms SJ, Parish CR. Isolation, tissue distribution, and chromosomal localization of a novel testis-specific human four-transmembrane gene related to CD20 and FcepsilonRI-beta. Biochemical and Biophysical Research Communications. 280: 374-9. PMID 11162526 DOI: 10.1006/Bbrc.2000.4088  0.603
2001 Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. Journal of Immunology (Baltimore, Md. : 1950). 166: 1781-9. PMID 11160224 DOI: 10.4049/Jimmunol.166.3.1781  0.494
2000 Rigby LJ, Trist H, Snider J, Hulett MD, Hogarth PM, Rigby LJ, Epa VC. Monoclonal antibodies and synthetic peptides define the active site of FcepsilonRI and a potential receptor antagonist. Allergy. 55: 609-19. PMID 10921459 DOI: 10.1034/j.1398-9995.2000.00485.x  0.659
2000 Wines BD, Powell MS, Parren PW, Barnes N, Hogarth PM. The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A. Journal of Immunology (Baltimore, Md. : 1950). 164: 5313-8. PMID 10799893 DOI: 10.4049/Jimmunol.164.10.5313  0.382
2000 Vukovic P, Hogarth PM, Barnes N, Kaslow DC, Good MF. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors. Infection and Immunity. 68: 3019-22. PMID 10769007 DOI: 10.1128/iai.68.5.3019-3022.2000  0.314
2000 Rigby LJ, Chandana Epa V, Mackay GA, Hulett MD, Sutton BJ, Gould HJ, Hogarth PM. Domain one of the high affinity IgE receptor, FcεRI, regulates binding to IgE through its interface with domain two Journal of Biological Chemistry. 275: 9664-9672. PMID 10734118 DOI: 10.1074/jbc.275.13.9664  0.628
1999 Powell MS, Barton PA, Emmanouilidis D, Wines BD, Neumann GM, Peitersz GA, Maxwell KF, Garrett TP, Hogarth PM. Biochemical analysis and crystallisation of Fc gamma RIIa, the low affinity receptor for IgG. Immunology Letters. 68: 17-23. PMID 10397151 DOI: 10.1016/S0165-2478(99)00025-5  0.341
1999 Maxwell KF, Powell MS, Hulett MD, Barton PA, McKenzie IF, Garrett TP, Hogarth PM. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nature Structural Biology. 6: 437-42. PMID 10331870 DOI: 10.1038/8241  0.66
1999 Hulett MD, Brinkworth RI, McKenzie IF, Hogarth PM. Fine structure analysis of interaction of FcepsilonRI with IgE. The Journal of Biological Chemistry. 274: 13345-52. PMID 10224096 DOI: 10.1074/jbc.274.19.13345  0.635
1999 Wines BD, Hulett MD, Jamieson GP, Trist HM, Spratt JM, Hogarth PM. Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA. Journal of Immunology (Baltimore, Md. : 1950). 162: 2146-53. PMID 9973489  0.345
1998 Hulett MD, Hogarth PM. The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a. Molecular Immunology. 35: 989-96. PMID 9881694 DOI: 10.1016/S0161-5890(98)00069-8  0.667
1998 Gavin AL, Tan PS, Hogarth PM. Gain-of-function mutations in FcgammaRI of NOD mice: implications for the evolution of the Ig superfamily. The Embo Journal. 17: 3850-7. PMID 9670002 DOI: 10.1093/Emboj/17.14.3850  0.42
1998 Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. Journal of Immunology (Baltimore, Md. : 1950). 160: 20-3. PMID 9551950  0.336
1996 Kershaw MH, Darcy PK, Hulett MD, Hogarth PM, Trapani JA, Smyth MJ. Redirected cytotoxic effector function. Requirements for expression of chimeric single chain high affinity immunoglobulin e receptors. The Journal of Biological Chemistry. 271: 21214-20. PMID 8702893 DOI: 10.1074/Jbc.271.35.21214  0.695
1996 Gavin AL, Hamilton JA, Hogarth PM. Extracellular mutations of non-obese diabetic mouse FcgammaRI modify surface expression and ligand binding. The Journal of Biological Chemistry. 271: 17091-9. PMID 8663283 DOI: 10.1074/Jbc.271.29.17091  0.404
1995 Hulett MD, Witort E, Brinkworth RI, McKenzie IF, Hogarth PM. Multiple regions of human Fc gamma RII (CD32) contribute to the binding of IgG. The Journal of Biological Chemistry. 270: 21188-94. PMID 7673151 DOI: 10.1074/Jbc.270.36.21188  0.669
1994 Hulett MD, Witort E, Brinkworth RI, McKenzie IF, Hogarth PM. Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. The Journal of Biological Chemistry. 269: 15287-93. PMID 8195166  0.445
1994 Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Advances in Immunology. 57: 1-127. PMID 7872156 DOI: 10.1016/S0065-2776(08)60671-9  0.642
1994 Hogarth PM, Ierino FL, Hulett MD. Characterization of FcR Ig-binding sites and epitope mapping. Immunomethods. 4: 17-24. PMID 7520815 DOI: 10.1006/Immu.1994.1003  0.7
1993 Quilliam AL, Osman N, McKenzie IF, Hogarth PM. Biochemical characterization of murine Fc gamma RI. Immunology. 78: 358-63. PMID 8478020  0.307
1993 Hulett MD, McKenzie IF, Hogarth PM. Chimeric Fc receptors identify immunoglobulin-binding regions in human Fc gamma RII and Fc epsilon RI. European Journal of Immunology. 23: 640-5. PMID 8449212 DOI: 10.1002/Eji.1830230310  0.693
1993 Ierino FL, Hulett MD, McKenzie IF, Hogarth PM. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors. Journal of Immunology (Baltimore, Md. : 1950). 150: 1794-803. PMID 7679695  0.376
1992 Tate BJ, Witort E, McKenzie IF, Hogarth PM. Expression of the high responder/non-responder human Fc gamma RII. Analysis by PCR and transfection into FcR-COS cells. Immunology and Cell Biology. 79-87. PMID 1398776 DOI: 10.1038/icb.1992.12  0.316
1992 Hogarth PM, Hulett MD, Ierino FL, Tate B, Powell MS, Brinkworth RI. Identification of the immunoglobulin binding regions (IBR) of Fc gamma RII and Fc epsilon RI. Immunological Reviews. 125: 21-35. PMID 1372589 DOI: 10.1111/J.1600-065X.1992.Tb00623.X  0.644
1992 Grattage LP, McKENZIE IFC, Hogarth PM. Effects of PMA, cytokines and dexamethasone on the expression of cell surface Fc receptors and mRNA in U937 cells. Immunology and Cell Biology. 70: 97-105. PMID 1356919 DOI: 10.1038/Icb.1992.14  0.326
1992 Hogarth PM, Hulett MD, Osman N. Fc gamma receptors: gene structure and receptor function. Immunologic Research. 11: 217-25. PMID 1287117 DOI: 10.1007/Bf02919128  0.631
1991 Hulett MD, Osman N, McKenzie IF, Hogarth PM. Chimeric Fc receptors identify functional domains of the murine high affinity receptor for IgG. Journal of Immunology (Baltimore, Md. : 1950). 147: 1863-8. PMID 1832426  0.365
1991 Sautès C, Varin N, Teillaud C, Daëron M, Even J, Hogarth PM, Fridman WH. Soluble Fcγ receptors II (FcγRII) are generated by cleavage of membrane FcγRII European Journal of Immunology. 21: 231-234. PMID 1825058 DOI: 10.1002/Eji.1830210135  0.44
1990 Sears DW, Osman N, Tate B, McKenzie IF, Hogarth PM. Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. Journal of Immunology (Baltimore, Md. : 1950). 144: 371-8. PMID 2136886  0.372
1989 Daëron M, Sautès C, Bonnerot C, Blank U, Varin N, Even J, Hogarth PM, Fridman WH. Murine type II Fc gamma receptors and IgG-binding factors. Chemical Immunology. 47: 21-78. PMID 2532892 DOI: 10.1159/000318912  0.307
1989 Varin N, Sautès C, Galinha A, Even J, Hogarth PM, Fridman WH. Recombinant soluble receptors for the Fcγ portion inhibit antibody production in vitro European Journal of Immunology. 19: 2263-2268. PMID 2532600 DOI: 10.1002/Eji.1830191213  0.48
1988 Parish CR, Hogarth PM, McKenzie IF. Evidence that Thy-1 and Ly-5 (T-200) antigens interact with sulphated carbohydrates. Immunology and Cell Biology. 66: 221-230. PMID 2908743 DOI: 10.1038/Icb.1988.28  0.448
1987 Hogarth PM, Hibbs ML, Bonadonna L, Scott BM, Witort E, Pietersz GA, McKenzie IF. The mouse Fc receptor for IgG (Ly-17): molecular cloning and specificity. Immunogenetics. 26: 161-8. PMID 2957319 DOI: 10.1007/Bf00365906  0.487
1986 Hibbs ML, Walker ID, Kirszbaum L, Pietersz GA, Deacon NJ, Chambers GW, McKenzie IF, Hogarth PM. The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proceedings of the National Academy of Sciences of the United States of America. 83: 6980-4. PMID 2944118 DOI: 10.1073/Pnas.83.18.6980  0.635
1986 Houlden BA, Hogarth PM, McKenzie IFC. Interrelationships of the “Ly-6 complex” antigens Immunogenetics. 23: 226-232. PMID 2422115 DOI: 10.1007/Bf00373017  0.337
1985 Sutton VR, Mickelson CA, Tobias GH, Hogarth PM, McKenzie IFC. Identification of two forms of the Ly-6.2 antigen showing differential expression Immunogenetics. 21: 539-547. PMID 3874158 DOI: 10.1007/Bf00395878  0.325
1985 Hibbs ML, Hogarth PM, McKenzie IFC. The mouse Ly-17 locus identifies a polymorphism of the Fc receptor. Immunogenetics. 22: 335-348. PMID 2414215 DOI: 10.1007/Bf00430917  0.454
1984 Hogarth PM, Houlden BA, Latham SE, Sutton VR, McKenzie IFC. Definition of new alloantigens encoded by genes in the Ly-6 complex Immunogenetics. 20: 57-69. PMID 6611306 DOI: 10.1007/Bf00373447  0.35
1984 Walker ID, Hogarth PM, Murray BJ, Lovering KE, Classon BJ, Chambers GW, McKenzie IF. Ly antigens associated with T cell recognition and effector function. Immunological Reviews. 82: 47-77. PMID 6442265 DOI: 10.1111/J.1600-065X.1984.Tb01117.X  0.302
1982 Hogarth PM, Crewther PE, McKenzie IFC. Description of a Qa-2 like alloantigen (Qa-m2). European Journal of Immunology. 12: 374-379. PMID 6980125 DOI: 10.1002/Eji.1830120504  0.329
1981 Michaelides M, Hogarth PM, McKenzie IFC. The immunosuppressive effect of monoclonal anti-Lyt-1.1 antibodies in vivo. European Journal of Immunology. 11: 1005-1012. PMID 6173235 DOI: 10.1002/Eji.1830111211  0.35
1980 Hogarth PM, Craig J, McKenzie IFC. A monoclonal antibody detecting the Ly-9.2 (Lgp 100) cell-membrane alloantigen. Immunogenetics. 11: 65-74. PMID 6160098 DOI: 10.1007/Bf01567770  0.37
Low-probability matches (unlikely to be authored by this person)
1981 Potter TA, Hogarth PM, McKenzie IF. Flow microfluorometric analysis of alloantigen expression during T cell development. European Journal of Immunology. 10: 899-903. PMID 7009163 DOI: 10.1002/Eji.1830101202  0.299
1984 Walker ID, Murray BJ, Hogarth PM, Kelso A, McKenzie IF. Comparison of thymic and peripheral T cell Ly-2/3 antigens. European Journal of Immunology. 14: 906-10. PMID 6208037 DOI: 10.1002/Eji.1830141009  0.297
1993 Ierino FL, Powell MS, McKenzie IF, Hogarth PM. Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction. The Journal of Experimental Medicine. 178: 1617-28. PMID 8228810 DOI: 10.1084/JEM.178.5.1617  0.294
2008 Powell MS, Hogarth PM. Fc receptors. Advances in Experimental Medicine and Biology. 640: 22-34. PMID 19065781 DOI: 10.1007/978-0-387-09789-3_3  0.294
2017 Vanderven HA, Liu L, Ana-Sosa-Batiz F, Nguyen TH, Wan Y, Wines B, Hogarth PM, Tilmanis D, Reynaldi A, Parsons MS, Hurt AC, Davenport MP, Kotsimbos T, Cheng AC, Kedzierska K, et al. Fc functional antibodies in humans with severe H7N9 and seasonal influenza. Jci Insight. 2. PMID 28679958 DOI: 10.1172/Jci.Insight.92750  0.291
2011 Wines BD, Ramsland PA, Trist HM, Gardam S, Brink R, Fraser JD, Hogarth PM. Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor. The Journal of Biological Chemistry. 286: 33118-24. PMID 21784854 DOI: 10.1074/jbc.M111.272252  0.291
1995 Gavin AL, Snider J, Hulett MD, Mckenzie IF, Hogarth PM. Expression of recombinant soluble Fc epsilon RI: function and tissue distribution studies. Immunology. 86: 392-8. PMID 8550076  0.291
1990 Webber LM, Garson OM, Tate B, McKenzie IF, Hogarth PM. Fc receptor gene translocation in a t(1;19) pre-B ALL cell line. Immunogenetics. 31: 356-60. PMID 2370080 DOI: 10.1007/Bf02115010  0.288
2012 Ko KK, Powell MS, Orlowski E, Prickett S, Krumbiegel D, Hogarth PM. Isolation, expansion and characterisation of alloreactive human Th17 and Th1 cells. Immunology Letters. 143: 116-21. PMID 22245119 DOI: 10.1016/J.Imlet.2011.12.007  0.287
2007 Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proceedings of the National Academy of Sciences of the United States of America. 104: 15051-6. PMID 17848512 DOI: 10.1073/pnas.0706028104  0.285
2018 Clark GJ, Silveira PA, Hogarth PM, Hart DNJ. THE CELL SURFACE PHENOTYPE OF HUMAN DENDRITIC CELLS. Seminars in Cell & Developmental Biology. PMID 29499385 DOI: 10.1016/J.Semcdb.2018.02.013  0.284
2019 Qiao J, Dunne E, Wines B, Kenny D, McCarthy GM, Hogarth PM, Xu K, Andrews RK, Gardiner EE. Plasma levels of the soluble form of the FcγRIIa receptor vary with receptor polymorphisms and are elevated in rheumatoid arthritis. Platelets. 1-7. PMID 31378115 DOI: 10.1080/09537104.2019.1647527  0.283
2022 Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, ... ... Hogarth PM, et al. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Frontiers in Immunology. 13: 889372. PMID 35967361 DOI: 10.3389/fimmu.2022.889372  0.282
2021 Feng G, Wines BD, Kurtovic L, Chan JA, Boeuf P, Mollard V, Cozijnsen A, Drew DR, Center RJ, Marshall DL, Chishimba S, McFadden GI, Dent AE, Chelimo K, Boyle MJ, ... ... Hogarth PM, et al. Mechanisms and targets of Fcγ-receptor mediated immunity to malaria sporozoites. Nature Communications. 12: 1742. PMID 33741975 DOI: 10.1038/s41467-021-21998-4  0.281
1991 Sautès C, Varin N, Hogarth PM, Unkeless JC, Teillaud C, Even J, Lynch A, Fridman WH. Molecular and functional studies of recombinant soluble Fc gamma receptors. Molecular Immunology. 27: 1201-7. PMID 2148805 DOI: 10.1016/0161-5890(90)90023-S  0.279
2021 Lee WS, Selva KJ, Davis SK, Wines BD, Reynaldi A, Esterbauer R, Kelly HG, Haycroft ER, Tan HX, Juno JA, Wheatley AK, Hogarth PM, Cromer D, Davenport MP, Chung AW, et al. Decay of Fc-dependent antibody functions after mild to moderate COVID-19. Cell Reports. Medicine. 100296. PMID 33997824 DOI: 10.1016/j.xcrm.2021.100296  0.278
2004 Godau J, Heller T, Hawlisch H, Trappe M, Howells E, Best J, Zwirner J, Verbeek JS, Hogarth PM, Gerard C, Van Rooijen N, Klos A, Gessner JE, Köhl J. C5a initiates the inflammatory cascade in immune complex peritonitis. Journal of Immunology (Baltimore, Md. : 1950). 173: 3437-45. PMID 15322209 DOI: 10.4049/Jimmunol.173.5.3437  0.276
2017 Ana-Sosa-Batiz F, Johnston APR, Hogarth PM, Wines BD, Barr I, Wheatley AK, Kent SJ. Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults. Vaccine. PMID 29029940 DOI: 10.1016/J.Vaccine.2017.09.062  0.276
2017 Yap ML, McFadyen JD, Wang X, Zia NA, Hohmann JD, Ziegler M, Yao Y, Pham A, Harris M, Donnelly PS, Hogarth PM, Pietersz GA, Lim B, Peter K. Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging. Theranostics. 7: 2565-2574. PMID 28819447 DOI: 10.7150/Thno.19900  0.274
2019 Yap ML, McFadyen JD, Wang X, Ziegler M, Chen YC, Willcox A, Nowell CJ, Scott AM, Sloan EK, Hogarth PM, Pietersz GA, Peter K. Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases. Theranostics. 9: 1154-1169. PMID 30867822 DOI: 10.7150/Thno.29146  0.27
2016 Wines BD, Yap ML, Powell MS, Tan PS, Ko KK, Orlowski E, Hogarth PM. Distinctive expression of Interleukin-23 receptor subunits on human Th17 and γδ T cells. Immunology and Cell Biology. PMID 27645493 DOI: 10.1038/Icb.2016.93  0.268
1988 Houlden BA, McKenzie IFC, Hogarth PM. The 33,000 protein precipitated by Ly-6A.2-specific antibodies is not associated with the Ly-6 polymorphism. Immunogenetics. 28: 399-405. PMID 3182014 DOI: 10.1007/Bf00355370  0.268
2020 Hartley GE, Edwards ESJ, Aui PM, Varese N, Stojanovic S, McMahon J, Peleg AY, Boo I, Drummer HE, Hogarth PM, O'Hehir RE, van Zelm MC. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence. Science Immunology. 5. PMID 33443036 DOI: 10.1126/sciimmunol.abf8891  0.263
1990 Zeger DL, Hogarth PM, Sears DW. Characterization and expression of an Fc gamma receptor cDNA cloned from rat natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 3425-9. PMID 1692135 DOI: 10.1073/pnas.87.9.3425  0.263
1993 Dietzsch E, Osman N, McKenzie IFC, Garson M, Hogarth PM. The human FCG1 gene encoding the high-affinity FcγRI maps to chromosome 1q21 Immunogenetics. 38: 307-309. PMID 8319983 DOI: 10.1007/Bf00188811  0.259
1985 Hogarth PM, Walker ID, McKenzie IFC, Springer TA. The Ly-15 alloantigenic system: A genetically determined polymorphism of the murine lymphocyte function-associated antigen-1 molecule Proceedings of the National Academy of Sciences of the United States of America. 82: 526-530. PMID 3881766 DOI: 10.1073/PNAS.82.2.526  0.259
1999 Marinaro JA, Jamieson GP, Hogarth PM, Bach LA. Differential dissociation kinetics explain the binding preference of insulin-like growth factor binding protein-6 for insulin-like growth factor-II over insulin-like growth factor-I. Febs Letters. 450: 240-4. PMID 10359082 DOI: 10.1016/S0014-5793(99)00499-8  0.257
1990 Zeger DL, Osman N, Hennings M, McKenzie IF, Sears DW, Hogarth PM. Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement receptor/Mac-1 antigen. Immunogenetics. 31: 191-7. PMID 1969385 DOI: 10.1007/BF00211555  0.256
1988 Hibbs ML, Bonadonna L, Scott BM, McKenzie IF, Hogarth PM. Molecular cloning of a human immunoglobulin G Fc receptor. Proceedings of the National Academy of Sciences of the United States of America. 85: 2240-4. PMID 2965389 DOI: 10.1073/pnas.85.7.2240  0.253
2018 Abadir E, Lee K, Li Z, Clarke C, Cooper WA, Gasiororwski RE, Ju X, Brown C, Bryant CE, Hsu JL, de St Groth BF, Hogarth PM, Cunningham I, Clark GJ, Hart DN. CD83 is a leading therapeutic target in Hodgkin and mantle cell lymphoma Pathology. 50: S101. DOI: 10.1016/J.Pathol.2017.12.282  0.252
1988 Hibbs ML, Classon BJ, Walker ID, McKenzie IFC, Hogarth PM. The structure of the murine Fc receptor for IgG. Assignment of intrachain disulfide bonds, identification of N-linked glycosylation sites, and evidence for a fourth form of Fc receptor Journal of Immunology. 140: 544-550. PMID 2961814  0.249
2019 Fromm PD, Silveira PA, Hsu JL, Papadimitrious MS, Lo TH, Ju X, Kupresanin F, Romano A, Hsu WH, Bryant CE, Kong B, Abadir E, Mekkawy A, M McGuire H, Groth BFS, ... ... Hogarth PM, et al. Distinguishing human peripheral blood CD16 myeloid cells based on phenotypic characteristics. Journal of Leukocyte Biology. PMID 31749181 DOI: 10.1002/Jlb.5A1119-362Rrr  0.247
2015 Ramnath D, Tunny K, Hohenhaus DM, Pitts CM, Bergot AS, Hogarth PM, Hamilton JA, Kapetanovic R, Sturm RA, Scholz GM, Sweet MJ. TLR3 drives IRF6-dependent IL-23p19 expression and p19/EBI3 heterodimer formation in keratinocytes. Immunology and Cell Biology. 93: 771-9. PMID 26303210 DOI: 10.1038/Icb.2015.77  0.246
1988 Sammartino L, Webber LM, Hogarth PM, McKenzie IF, Garson OM. Assignment of the gene coding for human FcRII (CD32) to bands q23q24 on chromosome 1. Immunogenetics. 28: 380-1. PMID 2971615 DOI: 10.1007/Bf00364238  0.246
2017 Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ. Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults. The Journal of Infectious Diseases. PMID 29106590 DOI: 10.1093/Infdis/Jix554  0.246
2005 Wong MX, Hayball JD, Hogarth PM, Jackson DE. The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. Journal of Clinical Immunology. 25: 19-28. PMID 15742154 DOI: 10.1007/S10875-005-0354-7  0.244
2021 Lemke MM, McLean MR, Lee CY, Lopez E, Bozich ER, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kratochvil S, Wines BD, Hogarth PM, Kent SJ, Chung AW, Arnold KB. A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination. Cell Reports. Medicine. 2: 100386. PMID 34622227 DOI: 10.1016/j.xcrm.2021.100386  0.244
1980 Hogarth PM, Potter TA, Cornell FN, McLachlan R, McKenzie IF. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1. Journal of Immunology (Baltimore, Md. : 1950). 125: 1618-24. PMID 6997382  0.244
1992 Osman N, Kozak CA, McKenzie IF, Hogarth PM. Structure and mapping of the gene encoding mouse high affinity Fc gamma RI and chromosomal location of the human Fc gamma RI gene. Journal of Immunology (Baltimore, Md. : 1950). 148: 1570-5. PMID 1531670  0.243
2015 Zhou J, Feng G, Beeson J, Hogarth PM, Rogerson SJ, Yan Y, Jaworowski A. CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so. Bmc Medicine. 13: 154. PMID 26149666 DOI: 10.1186/s12916-015-0391-7  0.242
1982 Hogarth PM, Edwards J, McKenzie IF, Goding JW, Liew FY. Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology. 46: 135-44. PMID 6176534  0.242
1991 Higgins TJ, Parish CR, Hogarth PM, McKenzie IF, Hämmerling GJ. Demonstration of carbohydrate- and protein determined Ia antigens by monoclonal antibodies. Immunogenetics. 11: 467-82. PMID 6086088 DOI: 10.1007/BF01567815  0.239
2020 Vanderven HA, Barr I, Reynaldi A, Wheatley AK, Wines BD, Davenport MP, Hogarth PM, Kent SJ. Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults. Vaccine. PMID 32035709 DOI: 10.1016/J.Vaccine.2020.01.066  0.238
2016 Dyer WB, Tan JC, Day T, Kiers L, Kiernan MC, Yiannikas C, Reddel S, Ng K, Mondy P, Dennington PM, Dean MM, Trist HM, Dos Remedios C, Hogarth PM, Vucic S, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain and Behavior. 6: e00516. PMID 27781132 DOI: 10.1002/Brb3.516  0.237
1986 Hibbs ML, Hogarth PM, Collins PR, McKenzie IF. The cell surface phenotype of mouse neutrophils. Journal of Immunogenetics. 12: 247-57. PMID 2422292 DOI: 10.1111/j.1744-313x.1985.tb00852.x  0.236
1987 Sutton VR, Wijffels GL, Walker ID, Hogarth PM, McKenzie IFC. Genetic and biochemical characterization of antigens encoded by the LY-24 (Pgp-1) locus Journal of Immunogenetics. 14: 43-57. PMID 2443580  0.232
1992 Alexander B, Berger R, Day LM, Hogarth PM, Feneziani A, Cook WD. Tumor-associated karyotypic lesions coselected with in vitro macrophage differentiation. Genes, Chromosomes & Cancer. 5: 286-98. PMID 1283317 DOI: 10.1002/Gcc.2870050404  0.231
2022 McKenzie CI, Varese N, Aui PM, Reinwald S, Wines BD, Hogarth PM, Thien F, Hew M, Rolland JM, O'Hehir RE, van Zelm MC. RNA sequencing of single allergen-specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect. Allergy. PMID 36153670 DOI: 10.1111/all.15529  0.23
2020 Chan JA, Loughland JR, de Labastida Rivera F, SheelaNair A, Andrew DW, Dooley NL, Wines BD, Amante FH, Webb L, Hogarth PM, McCarthy JS, Beeson JG, Engwerda CR, Boyle MJ. Th2-like T Follicular Helper Cells Promote Functional Antibody Production during Infection. Cell Reports. Medicine. 1: 100157. PMID 33377128 DOI: 10.1016/j.xcrm.2020.100157  0.227
1984 Hibbs ML, Hogarth PM, Scott BM, Harris RA, McKenzie IF. Monoclonal antibody to murine neutrophils: identification of the Gm-2.2 specificity. Journal of Immunology (Baltimore, Md. : 1950). 133: 2619-23. PMID 6207238  0.225
2008 Gardiner EE, Karunakaran D, Arthur JF, Mu FT, Powell MS, Baker RI, Hogarth PM, Kahn ML, Andrews RK, Berndt MC. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa. Blood. 111: 165-74. PMID 17848620 DOI: 10.1182/Blood-2007-04-086983  0.224
1980 Hogarth PM, Cruise KM, McKenzie IFC, Mitchell GF. Surface markers of a purified peritoneal eosinophil population from Mesocestoides corti-infected BALB/c male mice Journal of Immunology. 124: 406-411. PMID 6153100  0.222
1992 Oakey RJ, Howard TA, Hogarth PM, Tani K, Seldin MF. Chromosomal mapping of the high affinity Fc gamma receptor gene. Immunogenetics. 35: 279-82. PMID 1347284 DOI: 10.1007/BF00166834  0.222
1988 Daëron M, Bonnerot C, Sandor M, Varin N, Hogarth PM, Even J, Fridman WH. Molecular mechanisms regulating the expression of murine T-cell Fc gamma receptor II. Molecular Immunology. 25: 1143-50. PMID 2975760 DOI: 10.1016/0161-5890(88)90149-6  0.222
1991 Hogarth PM, Witort E, Hulett MD, Bonnerot C, Even J, Fridman WH, McKenzie IF. Structure of the mouse beta Fc gamma receptor II gene. Journal of Immunology (Baltimore, Md. : 1950). 146: 369-76. PMID 1824594  0.221
2022 Chan JA, Loughland JR, de la Parte L, Okano S, Ssewanyana I, Nalubega M, Nankya F, Musinguzi K, Rek J, Arinaitwe E, Tipping P, Bourke P, Andrew D, Dooley N, SheelaNair A, ... ... Hogarth PM, et al. Age-dependent changes in circulating Tfh cells influence development of functional malaria antibodies in children. Nature Communications. 13: 4159. PMID 35851033 DOI: 10.1038/s41467-022-31880-6  0.216
1984 Hogarth PM, Rigby A, Sutton VR, McKenzie IFC, Hilgers J. The Ly-25.1 specificity: Definition with a monoclonal antibody Immunogenetics. 19: 83-86. PMID 6693138 DOI: 10.1007/BF00364478  0.216
1993 Prins JB, Todd JA, Rodrigues NR, Ghosh S, Hogarth PM, Wicker LS, Gaffney E, Podolin PL, Fischer PA, Sirotina A. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science (New York, N.Y.). 260: 695-8. PMID 8480181 DOI: 10.1126/SCIENCE.8480181  0.212
2006 Barnes NC, Powell MS, Trist HM, Gavin AL, Wines BD, Hogarth PM. Raft localisation of FcgammaRIIa and efficient signaling are dependent on palmitoylation of cysteine 208. Immunology Letters. 104: 118-23. PMID 16375976 DOI: 10.1016/j.imlet.2005.11.007  0.211
1984 Hogarth PM, Latham SE, McKenzie IFC. A new murine alloantigen: Ly-26.1 Immunogenetics. 19: 355-358. PMID 6715025 DOI: 10.1007/Bf00345409  0.211
1981 Potter TA, Hogarth PM, McKenzie IF. Ly-15: a new murine lymphocyte alloantigenic locus. Transplantation. 31: 339-42. PMID 6785912  0.21
1985 Hogarth PM, Basten A, Prichard-Briscoe H, Henning MH, Sutton VR, McKenzie IF. The distribution of the Qa-2 alloantigen on functional T lymphocytes Journal of Immunology. 135: 1632-1636. PMID 3160773  0.207
1982 Hogarth PM, Henning MM, McKenzie IF. Alloantigenic phenotype of radiation-induced thymomas in the mouse. Journal of the National Cancer Institute. 69: 619-26. PMID 6125618  0.207
1995 Gavin AL, Wines BD, Powell MS, Hogarth PM. Recombinant soluble Fc gamma RII inhibits immune complex precipitation. Clinical and Experimental Immunology. 102: 620-5. PMID 8536382 DOI: 10.1111/j.1365-2249.1995.tb03862.x  0.206
1991 Jazwinska EC, Olive C, Hogarth PM, Gatenby PA, Serjeantson SW. Fc gamma RII restriction fragment length polymorphism (RFLP): analysis in systemic lupus erythematosus and scleroderma and evidence of an alpha gene duplication. Clinical and Experimental Immunology. 83: 47-51. PMID 1671005  0.205
1988 Scott BM, Hogarth PM, Scollay R, McKenzie IF. The expression of murine alloantigens on blood lymphocytes. Journal of Immunogenetics. 15: 281-93. PMID 3267151  0.204
1981 Shaw J, Pilarski LM, Al Adra AR, Leigh JB, Wilkins J, Hogarth PM, McKenzie IF, Paetkau V. Effect of a monoclonal anti-lyt-1.1 on the functional activity of precursor, effector, and regulatory cells specific for murine alloantigens. Transplantation. 31: 56-60. PMID 6165110 DOI: 10.1097/00007890-198101000-00013  0.203
2023 Selva KJ, Ramanathan P, Haycroft ER, Reynaldi A, Cromer D, Tan CW, Wang LF, Wines BD, Hogarth PM, Downie LE, Davis SK, Purcell RA, Kent HE, Juno JA, Wheatley AK, et al. Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections. Jci Insight. 8. PMID 37737263 DOI: 10.1172/jci.insight.172470  0.195
2023 Fryer HA, Hartley GE, Edwards ESJ, Varese N, Boo I, Bornheimer SJ, Hogarth PM, Drummer HE, O'Hehir RE, van Zelm MC. COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants. Journal of Clinical Immunology. PMID 37322095 DOI: 10.1007/s10875-023-01527-2  0.192
1985 Hibbs ML, Hogarth PM, Harris RA, McKenzie IF. Gm-3.2, a new granulocyte/macrophage alloantigen. Immunogenetics. 21: 61-70. PMID 3967899 DOI: 10.1007/BF00372242  0.191
1992 Ierino FL, Powell MS, McKenzie IF, Hogarth PM. Functional recombinant soluble human Fc gamma RII. Transplantation Proceedings. 24: 2326-7. PMID 1413080  0.19
2022 Lemke MM, Theisen RM, Bozich ER, McLean MR, Lee CY, Lopez E, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kratochvil S, Wines BD, Hogarth PM, Kent SJ, Chung AW, Arnold KB. A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination. Frontiers in Immunology. 13: 820148. PMID 35273603 DOI: 10.3389/fimmu.2022.820148  0.189
2021 Kurtovic L, Wetzel D, Reiling L, Drew DR, Palmer C, Kouskousis B, Hanssen E, Wines BD, Hogarth PM, Suckow M, Jenzelewski V, Piontek M, Chan JA, Beeson JG. Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Is Immunogenic and Induces Functional Antibody Responses in Mice. Frontiers in Immunology. 12: 641421. PMID 33815393 DOI: 10.3389/fimmu.2021.641421  0.188
1988 Bonnerot C, Daëron M, Varin N, Amigorena S, Hogarth PM, Even J, Fridman WH. Methylation in the 5' region of the murine beta Fc gamma R gene regulates the expression of Fc gamma receptor II. Journal of Immunology (Baltimore, Md. : 1950). 141: 1026-33. PMID 2456328  0.188
2018 Wines BD, Tan CW, Duncan E, McRae S, Baker RI, Andrews RK, Esparon S, Gardiner EE, Hogarth PM. Dimeric FcγR ectodomains detect pathogenic platelet factor 4-heparin antibodies in heparin induced thromobocytopenia. Journal of Thrombosis and Haemostasis : Jth. PMID 30269432 DOI: 10.1111/jth.14306  0.185
1989 Houlden BA, McKenzie IF, Hogarth PM. Cross-linking of Ly 6-linked alloantigens: association between ThB and Ly 5. Journal of Immunogenetics. 16: 33-43. PMID 2674290 DOI: 10.1111/j.1744-313x.1989.tb00445.x  0.182
2021 Anand SP, Ding S, Tolbert WD, Prévost J, Richard J, Gil HM, Gendron-Lepage G, Cheung WF, Wang H, Pastora R, Saxena H, Wakarchuk W, Medjahed H, Wines BD, Hogarth PM, et al. Enhanced ability of plant-derived PGT121 glycovariants to eliminate HIV-1-infected cells. Journal of Virology. JVI0079621. PMID 34232070 DOI: 10.1128/JVI.00796-21  0.18
2021 Oyong DA, Loughland JR, Soon MSF, Chan JA, Andrew D, Wines BD, Hogarth PM, Olver SD, Collinge AD, Varelias A, Beeson JG, Kenangalem E, Price RN, Anstey NM, Minigo G, et al. Adults with Plasmodium falciparum malaria have higher magnitude and quality of circulating T-follicular helper cells compared to children. Ebiomedicine. 75: 103784. PMID 34968760 DOI: 10.1016/j.ebiom.2021.103784  0.179
1983 Sutton VR, Hogarth PM, McKenzie IFC. Description of a new Qa antigenic specificity, 'Qa-m9', whose expression is under complex genetic control Journal of Immunology. 131: 1363-1367. PMID 6193187  0.179
2008 Golby P, Nunez J, Cockle PJ, Ewer K, Logan K, Hogarth P, Vordermeier HM, Hinds J, Hewinson RG, Gordon SV. Characterization of two in vivo-expressed methyltransferases of the Mycobacterium tuberculosis complex: antigenicity and genetic regulation. Microbiology (Reading, England). 154: 1059-67. PMID 18375799 DOI: 10.1099/mic.0.2007/014548-0  0.176
2021 Fulford TS, Van H, Gherardin NA, Zheng S, Ciula M, Drummer HE, Redmond S, Tan HX, Boo I, Center RJ, Li F, Grimley SL, Wines BD, Nguyen THO, Mordant FL, ... ... Hogarth PM, et al. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2. Ebiomedicine. 74: 103729. PMID 34871960 DOI: 10.1016/j.ebiom.2021.103729  0.173
2021 Aitken EH, Damelang T, Ortega-Pajares A, Alemu A, Hasang W, Dini S, Unger HW, Ome-Kaius M, Nielsen MA, Salanti A, Smith J, Kent S, Hogarth PM, Wines BD, Simpson JA, et al. Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria. Elife. 10. PMID 34181872 DOI: 10.7554/eLife.65776  0.172
1983 Harris RA, Hogarth PM, McKenzie IF, Penington DG. Differential expression of Qa-m2 alloantigen on murine hemopoietic progenitor cells. Selective enrichment for megakaryocyte progenitors. Experimental Hematology. 11: 527-41. PMID 6617788  0.17
2021 Yaffe ZA, Naiman NE, Slyker J, Wines BD, Richardson BA, Hogarth PM, Bosire R, Farquhar C, Ngacha DM, Nduati R, John-Stewart G, Overbaugh J. Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts. Cell Reports. Medicine. 2: 100254. PMID 33948582 DOI: 10.1016/j.xcrm.2021.100254  0.164
2022 Chua BY, Sekiya T, Koutsakos M, Nomura N, Rowntree LC, Nguyen THO, McQuilten HA, Ohno M, Ohara Y, Nishimura T, Endo M, Itoh Y, Habel JR, Selva KJ, Wheatley AK, ... ... Hogarth PM, et al. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques. Plos Pathogens. 18: e1010891. PMID 36206307 DOI: 10.1371/journal.ppat.1010891  0.164
2020 Hartley GE, Edwards ESJ, Bosco JJ, Ojaimi S, Stirling RG, Cameron PU, Flanagan K, Plebanski M, Hogarth PM, O'Hehir RE, van Zelm MC. Influenza-specific IgG1 memory B-cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency. Clinical & Translational Immunology. 9: e1199. PMID 33088507 DOI: 10.1002/cti2.1199  0.157
2022 Hartley GE, Edwards ESJ, Varese N, Boo I, Aui PM, Bornheimer SJ, Hogarth PM, Drummer HE, O'Hehir RE, van Zelm MC. The second COVID-19 mRNA vaccine dose enhances the capacity of Spike-specific memory B cells to bind Omicron BA.2. Allergy. PMID 36541822 DOI: 10.1111/all.15624  0.148
1981 Loveland BE, Hogarth PM, Ceredig R, McKenzie IF. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. The Journal of Experimental Medicine. 153: 1044-57. PMID 7019377 DOI: 10.1084/jem.153.5.1044  0.148
2021 Xu H, Locarnini S, Wong D, Hammond R, Colledge D, Soppe S, Huynh T, Shaw T, Thompson AJ, Revill PA, Hogarth PM, Wines BD, Walsh R, Warner N. Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A. Journal of Hepatology. PMID 34371070 DOI: 10.1016/j.jhep.2021.07.031  0.145
2022 Feng G, Kurtovic L, Agius PA, Aitken EH, Sacarlal J, Wines BD, Hogarth PM, Rogerson SJ, Fowkes FJI, Dobaño C, Beeson JG. Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children. Bmc Medicine. 20: 289. PMID 36002841 DOI: 10.1186/s12916-022-02466-2  0.143
2017 Madhavi V, Kulkarni A, Shete A, Lee WS, Mclean MR, Kristensen AB, Ghate M, Wines BD, Hogarth PM, Parsons MS, Kelleher A, Cooper DA, Amin J, Emery S, Thakar M, et al. Effect of combination antiretroviral therapy on HIV-1-specific antibody-dependent cellular cytotoxicity responses in subtype B- and subtype C-infected cohorts. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28346319 DOI: 10.1097/QAI.0000000000001380  0.142
2021 Hensen L, Nguyen THO, Rowntree LC, Damelang T, Koutsakos M, Aban M, Hurt A, Harland KL, Auladell M, van de Sandt CE, Everitt A, Blacker C, Oyong DA, Loughland JR, Webb JR, ... ... Hogarth PM, et al. Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34607957 DOI: 10.1073/pnas.2109388118  0.138
1987 Hogarth PM, McKenzie IEC, Sutton VR, Curnow KM, Lee BK, Eicher EM. Mapping of the Mouse Ly-6, Xp-14, and Gdc-1 loci to chromosome 15 Immunogenetics. 25: 21-27. PMID 2880797 DOI: 10.1007/BF00768829  0.136
1985 Harris RA, Sandrin MS, Sutton VR, Hogarth PM, McKenzie IF, Penington DG. Variable expression of Qa-m7, Qa-m8, and Qa-m9 antigenic determinants on primitive hemopoietic precursor cells Journal of Cellular Physiology. 123: 451-458. PMID 2580849 DOI: 10.1002/jcp.1041230324  0.136
1983 Sandrin MS, Hogarth PM, McKenzie IF. Two "Qa" specificities: Qa-m7 and Qa-m8 defined by monoclonal antibodies. Journal of Immunology (Baltimore, Md. : 1950). 131: 546-7. PMID 6190932  0.132
2006 Goschnick MW, Lau LM, Wee JL, Liu YS, Hogarth PM, Robb LM, Hickey MJ, Wright MD, Jackson DE. Impaired "outside-in" integrin alphaIIbbeta3 signaling and thrombus stability in TSSC6-deficient mice. Blood. 108: 1911-8. PMID 16720835 DOI: 10.1182/blood-2006-02-004267  0.13
2016 Heimer G, Kerätär JM, Riley LG, Balasubramaniam S, Eyal E, Pietikäinen LP, Hiltunen JK, Marek-Yagel D, Hamada J, Gregory A, Rogers C, Hogarth P, Nance MA, Shalva N, Veber A, et al. MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder. American Journal of Human Genetics. PMID 27817865 DOI: 10.1016/j.ajhg.2016.09.021  0.127
1989 Comber PG, Rossman MD, Rappaport EF, Chien P, Hogarth PM, Schreiber AD. Modulation of human mononuclear phagocyte Fc gamma RII mRNA and protein. Cellular Immunology. 124: 292-307. PMID 2531041 DOI: 10.1016/0008-8749(89)90132-9  0.126
1988 Sautès C, Varin N, Daëron M, Bonnerot C, Marloie M, Hogarth P, Fridman W, Even J. Expression of murine and human Fcγreceptor II (FcγRII) cDNAs in mouse L cells International Journal of Immunopharmacology. 10: 54. DOI: 10.1016/0192-0561(88)90289-5  0.125
2015 Zhou J, Feng G, Beeson J, Hogarth PM, Rogerson SJ, Yan Y, Jaworowski A. Erratum to: CD14 hi CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so. Bmc Medicine. 13: 290. PMID 26619830 DOI: 10.1186/s12916-015-0530-1  0.124
2023 Habel JR, Chua BY, Kedzierski L, Selva KJ, Damelang T, Haycroft ER, Nguyen TH, Koay HF, Nicholson S, McQuilten HA, Jia X, Allen LF, Hensen L, Zhang W, van de Sandt CE, ... ... Hogarth PM, et al. Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations. Jci Insight. 8. PMID 37036008 DOI: 10.1172/jci.insight.167157  0.118
1984 Harris RA, Hogarth PM, Wadeson LJ, Collins P, McKenzie IF, Penington DG. An antigenic difference between cells forming early and late haematopoietic spleen colonies (CFU-S). Nature. 307: 638-41. PMID 6694753 DOI: 10.1038/307638a0  0.114
1985 Harris RA, Hogarth PM, Penington DG, McKenzie IF. Qa antigens and their differential distribution on lymphoid, myeloid and stem cells. Journal of Immunogenetics. 11: 265-81. PMID 6399516 DOI: 10.1111/j.1744-313x.1984.tb00814.x  0.112
2023 Papandreou A, Singh N, Gianfrancesco L, Budinger D, Barwick K, Agrotis A, Luft C, Shao Y, Lenaerts AS, Gregory A, Jeong SY, Hogarth P, Hayflick S, Barral S, Kriston-Vizi J, et al. Cardiac glycosides restore autophagy flux in an iPSC-derived neuronal model of WDR45 deficiency. Biorxiv : the Preprint Server For Biology. PMID 37745522 DOI: 10.1101/2023.09.13.556416  0.109
1989 Hogarth PM, Osman N, Sears DW, Vovos M, Witort CE, Even J, McKenzie IF. Molecular analysis of FcR of T cells and other cell types. Transplantation Proceedings. 21: 44-5. PMID 2784896  0.104
1986 Walker ID, Sandrin MS, Hogarth PM, Sutton VR, McKenzie IFC. Expression of Qa alloantigens on peripheral T cells: The relationship of the Qa-m2, 7, 8, 9 specificities Immunogenetics. 24: 90-94. PMID 2427442 DOI: 10.1007/BF00373115  0.104
2005 Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, Krainc D. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease Proceedings of the National Academy of Sciences of the United States of America. 102: 11023-11028. PMID 16043692 DOI: 10.1073/Pnas.0504921102  0.102
1992 Hogarth PM, McKenzie IF. Ly-15.2 and Ly-21.2 are distinct polymorphisms of the LFA-1 heavy chain. Immunogenetics. 36: 396-9. PMID 1526659 DOI: 10.1007/BF00218047  0.1
2005 Ramsland PA, Bradford TM, Farrugia W, Hogarth PM. Engineering immune system glycoproteins to form uniform crystalline lattices Acta Crystallographica Section a Foundations of Crystallography. 61: c230-c230. DOI: 10.1107/S0108767305090215  0.097
2000 Gavin AL, Leiter EH, Hogarth PM. Mouse FcgammaRI: identification and functional characterization of five new alleles. Immunogenetics. 51: 206-11. PMID 10752630 DOI: 10.1007/s002510050033  0.094
2021 Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, ... ... Hogarth PM, et al. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet. Infectious Diseases. PMID 33887208 DOI: 10.1016/S1473-3099(21)00200-0  0.093
2017 Aoun M, Corsetto PA, Nugue G, Montorfano G, Ciusani E, Crouzier D, Hogarth P, Gregory A, Hayflick S, Zorzi G, Rizzo AM, Tiranti V. Changes in Red Blood Cell membrane lipid composition: A new perspective into the pathogenesis of PKAN Molecular Genetics and Metabolism. 121: 180-189. PMID 28456385 DOI: 10.1016/J.Ymgme.2017.04.006  0.091
2024 Hsin L, Varese N, Aui PM, Wines BD, von Borstel A, Mascarell L, Hogarth PM, Hew M, O'Hehir RE, van Zelm MC. Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on basophils (CytoBas). The Journal of Allergy and Clinical Immunology. PMID 38360181 DOI: 10.1016/j.jaci.2024.02.002  0.088
1990 Lah M, Quelch K, Deacon NJ, McKenzie IF, Hogarth PM. Identification of the mouse beta Fc gamma RII polymorphism by direct sequencing of amplified genomic DNA. Immunogenetics. 31: 202-6. PMID 2138587 DOI: 10.1007/BF00211557  0.085
2015 Jacobs JV, Boyd JT, Hogarth P, Horak FB. Domains and correlates of clinical balance impairment associated with Huntington's disease. Gait & Posture. 41: 867-70. PMID 25797790 DOI: 10.1016/j.gaitpost.2015.02.018  0.083
1983 Hogarth PM, Walker ID, Rigby AJ, McKenzie IFC. The H-2dm1mutation and Qa antigens Immunogenetics. 18: 617-624. PMID 6606620 DOI: 10.1007/BF00345969  0.082
2023 Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, ... ... Hogarth PM, et al. Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Frontiers in Immunology. 13: 1122516. PMID 36703991 DOI: 10.3389/fimmu.2022.1122516  0.082
1988 Hogarth PM, Houlden BA, Latham SE, Cherry M, Taylor BA, McKenzie IF. The mouse Ly-12.1 specificity: genetic and biochemical relationship to Ly-1. Immunogenetics. 27: 383-7. PMID 3356451 DOI: 10.1007/BF00395135  0.081
2002 Hammerstad J, Hogarth P. Parkinson's disease: surgical options. Current Neurology and Neuroscience Reports. 1: 313-9. PMID 11898536 DOI: 10.1007/s11910-001-0084-9  0.079
2015 Woltjer RL, Reese LC, Richardson BE, Tran H, Green S, Pham T, Chalupsky M, Gabriel I, Light T, Sanford L, Jeong SY, Hamada J, Schwanemann LK, Rogers C, Gregory A, ... Hogarth P, et al. Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus. Molecular Genetics and Metabolism. PMID 26547561 DOI: 10.1016/J.Ymgme.2015.10.012  0.077
2014 Holmes KL, Fontes B, Hogarth P, Konz R, Monard S, Pletcher CH, Wadley RB, Schmid I, Perfetto SP. International Society for the Advancement of Cytometry cell sorter biosafety standards. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 85: 434-53. PMID 24634405 DOI: 10.1002/cyto.a.22454  0.076
2019 Jeong SY, Hogarth P, Placzek A, Gregory AM, Fox R, Zhen D, Hamada J, van der Zwaag M, Lambrechts R, Jin H, Nilsen A, Cobb J, Pham T, Gray N, Ralle M, et al. 4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN. Embo Molecular Medicine. e10489. PMID 31660701 DOI: 10.15252/Emmm.201910489  0.073
2004 Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayán J, Brocklebank D, Cherny SS, Cardon LR, Gray J, Dlouhy SR, ... ... Hogarth P, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America. 101: 3498-503. PMID 14993615 DOI: 10.1073/Pnas.0308679101  0.073
2012 Haack TB, Hogarth P, Kruer MC, Gregory A, Wieland T, Schwarzmayr T, Graf E, Sanford L, Meyer E, Kara E, Cuno SM, Harik SI, Dandu VH, Nardocci N, Zorzi G, et al. Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. American Journal of Human Genetics. 91: 1144-9. PMID 23176820 DOI: 10.1016/J.Ajhg.2012.10.019  0.073
2013 Haack TB, Hogarth P, Gregory A, Prokisch H, Hayflick SJ. BPAN: the only X-linked dominant NBIA disorder. International Review of Neurobiology. 110: 85-90. PMID 24209435 DOI: 10.1016/B978-0-12-410502-7.00005-3  0.071
2021 McKenzie CI, Varese N, Aui PM, Wines BD, Hogarth PM, Thien F, Hew M, Rolland JM, O'Hehir RE, van Zelm MC. CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers. Allergy. PMID 33772805 DOI: 10.1111/all.14832  0.07
2021 Wilson JL, Gregory A, Kurian MA, Bushlin I, Mochel F, Emrick L, Adang L, Hogarth P, Hayflick SJ. Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration. Developmental Medicine and Child Neurology. PMID 34347296 DOI: 10.1111/dmcn.14980  0.067
2013 Hayflick SJ, Kruer MC, Gregory A, Haack TB, Kurian MA, Houlden HH, Anderson J, Boddaert N, Sanford L, Harik SI, Dandu VH, Nardocci N, Zorzi G, Dunaway T, Tarnopolsky M, ... ... Hogarth P, et al. β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain : a Journal of Neurology. 136: 1708-17. PMID 23687123 DOI: 10.1093/Brain/Awt095  0.067
2022 Smith GC, Barber A, Breslin P, Birch C, Chambers M, Dave D, Hogarth P, Gormley E, Lesellier S, Balseiro A, Budgey R. Simulating partial vaccine protection: BCG in badgers. Preventive Veterinary Medicine. 204: 105635. PMID 35453089 DOI: 10.1016/j.prevetmed.2022.105635  0.066
2018 Lee JH, Gregory A, Hogarth P, Rogers C, Hayflick SJ. Looking Deep into the Eye-of-the-Tiger in Pantothenate Kinase-Associated Neurodegeneration. Ajnr. American Journal of Neuroradiology. PMID 29371252 DOI: 10.3174/Ajnr.A5514  0.065
2013 Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, et al. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology. 80: 268-75. PMID 23269600 DOI: 10.1212/Wnl.0B013E31827E07Be  0.065
1984 Hogarth PM, McKenzie IF, Lanier L, Bailey DW, Taylor BA. Location of Ly-7 on mouse chromosome 12. Immunogenetics. 19: 539-43. PMID 6735449 DOI: 10.1007/Bf00403445  0.064
2018 Hayflick SJ, Kurian MA, Hogarth P. Neurodegeneration with brain iron accumulation. Handbook of Clinical Neurology. 147: 293-305. PMID 29325618 DOI: 10.1016/B978-0-444-63233-3.00019-1  0.062
2007 Hogarth P, Lovrecic L, Krainc D. Sodium phenylbutyrate in Huntington's disease: a dose-finding study. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1962-4. PMID 17702032 DOI: 10.1002/Mds.21632  0.061
2019 Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, ... ... Hogarth P, et al. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Molecular Genetics & Genomic Medicine. e736. PMID 31087512 DOI: 10.1002/Mgg3.736  0.059
2007 Freeman K, Gregory A, Turner A, Blasco P, Hogarth P(, Hayflick S. Intellectual and adaptive behaviour functioning in pantothenate kinase-associated neurodegeneration. Journal of Intellectual Disability Research. 51: 417-426. PMID 17493025 DOI: 10.1111/J.1365-2788.2006.00889.X  0.059
2008 Nutt JG, Gunzler SA, Kirchhoff T, Hogarth P, Weaver JL, Krams M, Jamerson B, Menniti FS, Landen JW. Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1860-6. PMID 18759356 DOI: 10.1002/mds.22169  0.056
1986 Hogarth PM, Eicher EM, McKenzie IFC. Mapping of the murine Ly-15(LFA-1) locus to chromosome 7 Immunogenetics. 23: 348-349. PMID 3710538 DOI: 10.1007/BF00398800  0.055
2015 Long M, Abdeen N, Geraghty MT, Hogarth P, Hayflick S, Venkateswaran S. Novel WDR45 Mutation and Pathognomonic BPAN Imaging in a Young Female With Mild Cognitive Delay. Pediatrics. 136: e714-7. PMID 26240209 DOI: 10.1542/Peds.2015-0750  0.052
2021 Patel SK, Juno JA, Lee WS, Wragg KM, Hogarth PM, Kent SJ, Burrell LM. Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences. The European Respiratory Journal. PMID 33479113 DOI: 10.1183/13993003.03730-2020  0.052
2003 Hogarth P. Huntington's disease: a decade beyond gene discovery. Current Neurology and Neuroscience Reports. 3: 279-84. PMID 12930696 DOI: 10.1007/s11910-003-0003-3  0.052
2005 Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/Mds.20332  0.051
2012 Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 79: 55-65. PMID 22722632 DOI: 10.1212/Wnl.0B013E31825Dcdc1  0.05
2001 Polk TA, Reed CL, Keenan JM, Hogarth P, Anderson CA. A dissociation between symbolic number knowledge and analogue magnitude information. Brain and Cognition. 47: 545-63. PMID 11748908 DOI: 10.1006/Brcg.2001.1486  0.048
2023 Qi R, Sammler E, Gonzalez-Hunt CP, Barraza I, Pena N, Rouanet JP, Naaldijk Y, Goodson S, Fuzzati M, Blandini F, Erickson KI, Weinstein AM, Lutz MW, Kwok JB, Halliday GM, ... ... Hogarth P, et al. A blood-based marker of mitochondrial DNA damage in Parkinson's disease. Science Translational Medicine. 15: eabo1557. PMID 37647388 DOI: 10.1126/scitranslmed.abo1557  0.048
1992 Ierino FL, Miach PJ, Hogarth PM, McKenzie IF. Serum soluble Fc gamma RII levels in dialysis and renal transplant recipients. Transplantation Proceedings. 24: 2328. PMID 1413081  0.048
2013 Hogarth P. Huntington disease: How many repeats does it take? Neurology. 80: e241-3. PMID 23713095 DOI: 10.1212/WNL.0b013e3182984b31  0.044
2010 Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 362: 2077-91. PMID 20519680 DOI: 10.1056/Nejmoa0907083  0.043
2014 St George RJ, Carlson-Kuhta P, Nutt JG, Hogarth P, Burchiel KJ, Horak FB. The effect of deep brain stimulation randomized by site on balance in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 949-53. PMID 24532106 DOI: 10.1002/mds.25831  0.043
2004 Vordermeier M, Hogarth P. Vaccine development in the 21st century: a time of living dangerously. Veterinary Journal (London, England : 1997). 170: 271-2. PMID 16266840 DOI: 10.1016/j.tvjl.2004.10.004  0.043
2023 Wint W, Mitchell A, Alexander N, Ellerbeck J, Enticott G, Hogarth P, Prosser A, Lambert L, Hackett D, Tait N, Tiller J, Upton P. Challenges and opportunities of sharing animal health data for research and disease management: a case study of bovine tuberculosis. Revue Scientifique Et Technique (International Office of Epizootics). 42: 75-82. PMID 37232317 DOI: 10.20506/rst.42.3350  0.042
2019 Frank S, Berk S, Hernandez L, Hogarth P, Shill HA, Siddiqi B, Simon DK. Transportation innovation to aid Parkinson disease trial recruitment. Contemporary Clinical Trials Communications. 16: 100449. PMID 31650070 DOI: 10.1016/j.conctc.2019.100449  0.04
2020 Mohammad SS, Angiti RR, Biggin A, Morales-Briceño H, Goetti R, Perez-Dueñas B, Gregory A, Hogarth P, Ng J, Papandreou A, Bhattacharya K, Rahman S, Prelog K, Webster RI, Wassmer E, et al. Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders. Brain Communications. 2: fcaa178. PMID 33629063 DOI: 10.1093/braincomms/fcaa178  0.04
2012 Kruer MC, Boddaert N, Schneider SA, Houlden H, Bhatia KP, Gregory A, Anderson JC, Rooney WD, Hogarth P, Hayflick SJ. Neuroimaging features of neurodegeneration with brain iron accumulation. Ajnr. American Journal of Neuroradiology. 33: 407-14. PMID 21920862 DOI: 10.3174/Ajnr.A2677  0.04
2021 Spaull RVV, Soo AKS, Hogarth P, Hayflick SJ, Kurian MA. Towards Precision Therapies for Inherited Disorders of Neurodegeneration with Brain Iron Accumulation. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 11: 51. PMID 34909266 DOI: 10.5334/tohm.661  0.04
2021 Patel S, Juno J, Lee WS, Wragg K, Hogarth PM, Kent S, Burrell L. PLASMA ACE2 ACTIVITY IS INCREASED IN PATIENTS RECOVERED FROM SARS-COV-2 INFECTION: IMPLICATIONS FOR THE PROLONGED CONSEQUENCES OF COVID-19 Journal of Hypertension. 39: e394. DOI: 10.1097/01.HJH.0000749140.12677.66  0.039
2008 Gregory A, Westaway SK, Holm IE, Kotzbauer PT, Hogarth P, Sonek S, Coryell JC, Nguyen TM, Nardocci N, Zorzi G, Rodriguez D, Desguerre I, Bertini E, Simonati A, Levinson B, et al. Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology. 71: 1402-9. PMID 18799783 DOI: 10.1212/01.Wnl.0000327094.67726.28  0.038
2011 Kruer MC, Hiken M, Gregory A, Malandrini A, Clark D, Hogarth P, Grafe M, Hayflick SJ, Woltjer RL. Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. Brain : a Journal of Neurology. 134: 947-58. PMID 21459825 DOI: 10.1093/Brain/Awr042  0.038
2010 Timmermann L, Pauls KA, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, et al. Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain : a Journal of Neurology. 133: 701-12. PMID 20207700 DOI: 10.1093/Brain/Awq022  0.037
2015 Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Hogarth P, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736  0.037
2005 Egan RA, Weleber RG, Hogarth P, Gregory A, Coryell J, Westaway SK, Gitschier J, Das S, Hayflick SJ. Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). American Journal of Ophthalmology. 140: 267-74. PMID 16023068 DOI: 10.1016/J.Ajo.2005.03.024  0.037
2013 Goldman JG, Eichenseer SR, Berry-Kravis E, Zimnowodzki S, Gregory A, Hogarth P, Hayflick SJ. Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1462-3. PMID 23494994 DOI: 10.1002/Mds.25410  0.036
2020 Lee JH, Yun JY, Gregory A, Hogarth P, Hayflick SJ. Brain MRI Pattern Recognition in Neurodegeneration With Brain Iron Accumulation. Frontiers in Neurology. 11: 1024. PMID 33013674 DOI: 10.3389/Fneur.2020.01024  0.035
2012 Agarwal P, Hogarth P, Hayflick S, MacLeod P, Kuriakose R, McKenzie J, Heffernan N, Dinelle K, Sossi V, Stoessl AJ. Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1698-9. PMID 23192926 DOI: 10.1002/Mds.25160  0.034
2011 Vedam-Mai V, Krock N, Ullman M, Foote KD, Shain W, Smith K, Yachnis AT, Steindler D, Reynolds B, Merritt S, Pagan F, Marjama-Lyons J, Hogarth P, Resnick AS, Zeilman P, et al. The national DBS brain tissue network pilot study: need for more tissue and more standardization. Cell and Tissue Banking. 12: 219-31. PMID 20589432 DOI: 10.1007/S10561-010-9189-1  0.034
2012 St George RJ, Carlson-Kuhta P, Burchiel KJ, Hogarth P, Frank N, Horak FB. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. Journal of Neurosurgery. 116: 1347-56. PMID 22424564 DOI: 10.3171/2012.2.JNS11847  0.034
2015 Hogarth P. Neurodegeneration with brain iron accumulation: diagnosis and management. Journal of Movement Disorders. 8: 1-13. PMID 25614780 DOI: 10.14802/jmd.14034  0.033
2013 Williams S, Gregory A, Hogarth P, Hayflick SJ, Gillingham MB. Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration. Molecular Genetics and Metabolism. 110: 336-41. PMID 23891537 DOI: 10.1016/J.Ymgme.2013.06.017  0.032
2022 Inayatillah A, Haigh ID, Brand JH, Francis K, Mortley A, Durrant M, Fantuzzi L, Palmer E, Miller C, Hogarth P. Digitising historical sea level records in the Thames Estuary, UK. Scientific Data. 9: 167. PMID 35414062 DOI: 10.1038/s41597-022-01223-7  0.031
2022 Gregory A, Wilson JL, Hogarth P, Hayflick SJ. Abnormal Brain Iron Accumulation is a Rare Finding in Down Syndrome Regression Disorder. Pediatric Neurology. 138: 1-4. PMID 36270151 DOI: 10.1016/j.pediatrneurol.2022.09.002  0.031
2016 Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, et al. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27113479 DOI: 10.1002/Mds.26613  0.03
2011 Robertson LT, St George RJ, Carlson-Kuhta P, Hogarth P, Burchiel KJ, Horak FB. Site of deep brain stimulation and jaw velocity in Parkinson disease. Journal of Neurosurgery. 115: 985-94. PMID 21838506 DOI: 10.3171/2011.7.JNS102173  0.029
2019 Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, et al. Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism & Related Disorders. PMID 31255537 DOI: 10.1016/J.Parkreldis.2019.06.017  0.029
2023 Behrndt L, Gregory A, Wakeman K, Freed A, Wilson JL, Spaull R, Kurian MA, Mordekar S, Fernandes JA, Hayflick SJ, Hogarth P, Yang S. Femur Fractures in 5 Individuals With Pantothenate Kinase-associated Neurodegeneration: The Role of Dystonia and Suggested Management. Journal of Pediatric Orthopedics. PMID 37867374 DOI: 10.1097/BPO.0000000000002555  0.029
2019 Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmieć T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, ... ... Hogarth P, et al. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. The Lancet. Neurology. 18: 631-642. PMID 31202468 DOI: 10.1016/S1474-4422(19)30142-5  0.028
2019 Middlemiss C, de la Rua-Domenech R, Downs S, Smith G, Brown E, McCormack J, Wade C, Hogarth P, Gerrard Z. TB testing and levels of bovine TB in England. The Veterinary Record. 185: 664. PMID 31780509 DOI: 10.1136/vr.l6696  0.027
2020 Frederikse T, Landerer F, Caron L, Adhikari S, Parkes D, Humphrey VW, Dangendorf S, Hogarth P, Zanna L, Cheng L, Wu YH. The causes of sea-level rise since 1900. Nature. 584: 393-397. PMID 32814886 DOI: 10.1038/s41586-020-2591-3  0.026
2005 Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Archives of Neurology. 62: 554-60. PMID 15824252 DOI: 10.1001/ARCHNEUR.62.4.554  0.024
2009 Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama. 301: 63-73. PMID 19126811 DOI: 10.1001/Jama.2008.929  0.024
2019 Wilson JL, Gregory A, Wakeman K, Freed A, Rai P, Roberts C, Hayflick SJ, Hogarth P. Cannabis Use in Children With Pantothenate Kinase-Associated Neurodegeneration. Journal of Child Neurology. 883073819890516. PMID 31823681 DOI: 10.1177/0883073819890516  0.021
2006 Brodsky MA, Hogarth P, Nutt JG. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1487-90. PMID 16721730 DOI: 10.1002/mds.20964  0.021
2017 Chahine LM, Uribe L, Hogarth P, McNames J, Siderowf A, Marek K, Jennings D. Portable objective assessment of upper extremity motor function in Parkinson's disease. Parkinsonism & Related Disorders. PMID 28747279 DOI: 10.1016/J.Parkreldis.2017.07.017  0.021
2016 Hogarth P, Kurian MA, Gregory A, Csányi B, Zagustin T, Kmiec T, Wood P, Klucken A, Scalise N, Sofia F, Klopstock T, Zorzi G, Nardocci N, Hayflick SJ. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN). Molecular Genetics and Metabolism. PMID 28034613 DOI: 10.1016/J.Ymgme.2016.11.004  0.02
2011 Hayflick SJ, Hogarth P. As iron goes, so goes disease? Haematologica. 96: 1571-2. PMID 22058278 DOI: 10.3324/Haematol.2011.055335  0.02
2018 Chung KA, Lobb BM, Murchison CF, Mancini M, Hogarth P, Nutt JG. Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's Disease. Movement Disorders Clinical Practice. 5: 160-164. PMID 30363374 DOI: 10.1002/mdc3.12583  0.02
2012 Rocchi L, Carlson-Kuhta P, Chiari L, Burchiel KJ, Hogarth P, Horak FB. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. Journal of Neurosurgery. 117: 1141-9. PMID 23039143 DOI: 10.3171/2012.8.JNS112006  0.019
2017 Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, et al. Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29205509 DOI: 10.1002/Mds.27232  0.017
2005 Follett K, Weaver F, Stern M, Marks W, Hogarth P, Holloway K, Bronstein J, Duda J, Horn S, Lai E, Samii A, Okun MS, Foote KD. Multisite randomized trial of deep brain stimulation [4] (multiple letters) Archives of Neurology. 62: 1643-1645. PMID 16216957 DOI: 10.1001/archneur.62.10.1643-b  0.012
Hide low-probability matches.